632
Views
47
CrossRef citations to date
0
Altmetric
Clinical Research Articles

PCBaSe Sweden: A register-based resource for prostate cancer research

, , , , , , & show all
Pages 342-349 | Received 02 Dec 2008, Published online: 18 Nov 2009

References

  • National Center for Health Statistics. The personal number system of Sweden, Norway, Denmark and Israel. Vital and health statistics, Series 2, No. 84, AS Lunde. Government Printing Office, Washington, DC 1980
  • Hansson LE, Nyren O, Hsing AW, Bergstrom R, Josefsson S, Chow WH, et al. The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N Engl J Med 1996; 335: 242–9
  • Jarvholm B, Englund A, Albin M. Pleural mesothelioma in Sweden: an analysis of the incidence according to the use of asbestos. Occup Environ Med 1999; 56: 110–3
  • Hemminki K, Li X. Level of education and the risk of cancer in Sweden. Cancer Epidemiol Biomarkers Prev 2003; 12: 796–802
  • Luo J, Ye W, Zendehdel K, Adami J, Adami HO, Boffetta P, et al. Oral use of Swedish moist snuff (snus) and risk for cancer of the mouth, lung, and pancreas in male construction workers: a retrospective cohort study. Lancet 2007; 369: 2015–20
  • Hjalgrim H, Edgren G, Rostgaard K, Reilly M, Tran TN, Titlestad KE, et al. Cancer incidence in blood transfusion recipients. J Natl Cancer Inst 2007; 99: 1864–74
  • Adolfsson J, Garmo H, Varenhorst E, Ahlgren G, Ahlstrand C, Andren O, et al. Clinical characteristics and primary treatment of prostate cancer in Sweden between 1996 and 2005. Scand J Urol Nephrol 2007; 41: 456–77
  • Varenhorst E, Garmo H, Holmberg L, Adolfsson J, Damber JE, Hellstrom M, et al. The National Prostate Cancer Register in Sweden 1998–2002: trends in incidence, treatment and survival. Scand J Urol Nephrol 2005; 39: 117–23
  • LHWC Sobin, TNM classification of malignant tumors. 5th ed. New York: John Wiley & Sons; 1997.
  • Stattin P, Holmberg E, Bratt O, Adolfsson J, Johansson JE, Hugosson J. Surveillance and deferred treatment for localized prostate cancer. Population based study in the National Prostate Cancer Register of Sweden. J Urol 2008; 180: 2423–9
  • International Health Terminology Standards Development Organization. http://www.ihtsdo.org/.
  • Regional Oncological Center (ROC). NPCR Manual Description. http://www.roc.se/prostata/manual/manual_prostata.pdf.
  • National Board of Health and Welfare, Centre for Epidemiology. http://www.socialstyrelsen.se/en/about/epc/.
  • Barlow L, Westergren K, Holmberg L, Talback M. The completeness of the Swedish Cancer Register: a sample survey for year 1998. Acta Oncol 2009; 48: 27–33
  • Fall K, Stromberg F, Rosell J, Andren O, Varenhorst E. Reliability of death certificates in prostate cancer patients. Scand J Urol Nephrol 2008; 42: 352–7
  • Statistics Sweden. http://www.scb.se.
  • Wettermark B, Hammar N, Fored CM, Leimanis A, Otterblad Olausson P, Bergman U, et al. The new Swedish Prescribed Drug Register – opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf 2007; 16: 726–35
  • Frisk P, Mellgren TO, Hedberg N, Berlin A, Granath F, Wettermark B. Utilisation of angiotensin receptor blockers in Sweden: combining survey and register data to study adherence to prescribing guidelines. Eur J Clin Pharmacol 2008; 64: 1223–9
  • National Board of Health and Welfare. Quality and content of the National Patient Register. Discharges from in-patient care 1964–2006 and attendance in out-patient care (excluding primary health care) 1997–2006. (In Swedish.), http://www.socialstyrelsen.se/NR/rdonlyres/3FE32D5A-E276-4AE0-8FB9-67A4F4B497F4/10193/20081251_rev.pdf.
  • National Board of Health and Welfare, Centre for Epidemiology . Official statistics of Sweden: myocardial infarctions 1987–2005 (In Swedish.), http://www.socialstyrelsen.se/NR/rdonlyres/690DCBE5-FAB5-41F0-ABAF-B0576190FA3A/9940/2008421.pdf.
  • Giwercman A, Richiardi L, Kaijser M, Ekbom A, Akre O. Reduced risk of prostate cancer in men who are childless as compared to those who have fathered a child: a population based case–control study. Int J Cancer 2005;20; 115: 994–7
  • Swedish Hernia Register. http://www.svensktbrackregister.se/.
  • Nordin P, van der Linden W. Volume of procedures and risk of recurrence after repair of groin hernia: national register study. BMJ 2008; 336: 934–7
  • Lund L, Borre M, Jacobsen J, Sorensen HT, Norgaard M. Impact of comorbidity on survival of Danish prostate cancer patients, 1995–2006: a population-based cohort study. Urology 2008; 72: 1258–62
  • Alibhai SM, Leach M, Tomlinson GA, Krahn MD, Fleshner NE, Naglie G. Is there an optimal comorbidity index for prostate cancer?. Cancer 2008; 112: 1043–50
  • Sandblom G, Dufmats M, Olsson M, Varenhorst E. Validity of a population-based cancer register in Sweden – an assessment of data reproducibility in the South-East Region Prostate Cancer Register. Scand J Urol Nephrol 2003; 37: 112–9
  • Suicide rates by age. J Natl Cancer Inst. 2008;100:1751.
  • Abrahamsen B, Nielsen MF, Eskildsen P, Andersen JT, Walter S, Brixen K. Fracture risk in Danish men with prostate cancer: a nationwide register study. BJU Int 2007; 100: 749–54
  • Dickman PW, Adolfsson J, Astrom K, Steineck G. Hip fractures in men with prostate cancer treated with orchiectomy. J Urol 2004; 172: 2208–12
  • Thellenberg C, Malmer B, Tavelin B, Gronberg H. Second primary cancers in men with prostate cancer: an increased risk of male breast cancer. J Urol 2003; 169: 1345–8
  • Wong YN, Mitra N, Hudes G, Localio R, Schwartz JS, Wan F, et al. Survival associated with treatment vs observation of localized prostate cancer in elderly men. JAMA 2006; 296: 2683–93
  • Shahinian VB, Kuo YF, Freeman JL, Goodwin JS. Determinants of androgen deprivation therapy use for prostate cancer: role of the urologist. J Natl Cancer Inst 2006; 98: 839–45
  • Partridge AH, LaFountain A, Mayer E, Taylor BS, Winer E, Asnis-Alibozek A. Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer. J Clin Oncol 2008; 26: 556–62
  • Keating NL, O'Malley AJ, Smith MR. Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer. J Clin Oncol 2006; 24: 4448–56
  • Efstathiou JA, Bae K, Shipley WU, Hanks GE, Pilepich MV, Sandler HM, et al. Cardiovascular mortality after androgen deprivation therapy for locally advanced prostate cancer: rTOG 85-31. J Clin Oncol 2009; 27: 92–9
  • Roehl KA, Loeb S, Antenor JA, Corbin N, Catalona WJ. Characteristics of patients with familial versus sporadic prostate cancer. J Urol 2006; 176: 2438–42
  • Sacco E, Prayer-Galetti T, Pinto F, Ciaccia M, Fracalanza S, Betto G, et al. Familial and hereditary prostate cancer by definition in an Italian surgical series: clinical features and outcome. Eur Urol 2005; 47: 761–8
  • Eaker S, Halmin M, Bellocco R, Bergkvist L, Ahlgren J, Holmberg L, et al. Social differences in breast cancer survival in relation to patient management within a National Health Care System (Sweden). Int J Cancer 2009; 124: 180–7
  • Stranne J, Hugosson J, Lodding P. Inguinal hernia is a common complication in lower midline incision surgery. Hernia 2007; 11: 247–52
  • Koie T, Yoneyama T, Kamimura N, Imai A, Okamoto A, Ohyama C. Frequency of postoperative inguinal hernia after endoscope-assisted mini-laparotomy and conventional retropubic radical prostatectomies. Int J Urol 2008; 15: 226–9

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.